Patients sought for hot flashes, atrial fibrillation and neuroimaging studies
DALLAS — May 9, 2008 — Researchers at UT Southwestern Medical Center are seeking patients to participate in medical studies on hot flashes, atrial fibrillation and neuroimaging. All clinical trials are approved by UT Southwestern’s Institutional Review Board, which reviews them for benefits, risks, side effects and informed consent.
UT Southwestern Medical Center scientists are conducting a research study of a highly refined, concentrated Omega-3 fatty acid to determine its safety and effectiveness in the treatment of atrial fibrillation. The medication is already approved to help lower high triglycerides. Eligible participants must be at least 18 years old and have a history of atrial fibrillation espisodes and symptoms associated with the condition. Female candidates for the study must not be pregnant or breast feeding. For more information about the clinical trial, call 214-590-5015.
Researchers at UT Southwestern Medical Center are seeking healthy adults between the ages of 18 and 50 to participate in a functional magnetic resonance imaging (fMRI) research study. Participants will be involved in four imaging sessions and five assessment sessions. Each session lasts approximately two hours. Participants will have to take two medications for four days before each fMRI. Compensation is available. For more information please contact Daren Denniston at 214-645-6963 or Michael Lawlor at 214-645-6956.
Media Contact: Katherine Morales
To automatically receive news releases from UT Southwestern via e-mail, subscribe at www.utsouthwestern.edu/receivenews